Schonfeld Strategic Advisors LLC - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 339 filers reported holding ACCELERON PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.5%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$1,343,000
-34.6%
7,807
-52.3%
0.01%
-36.4%
Q2 2021$2,054,000
+82.4%
16,368
+97.2%
0.02%
+57.1%
Q1 2021$1,126,000
+72.4%
8,300
+62.7%
0.01%
+55.6%
Q4 2020$653,000
-68.1%
5,100
-76.2%
0.01%
-66.7%
Q2 2020$2,044,000
+34.7%
21,452
-25.0%
0.03%
-27.0%
Q4 2019$1,517,000
+36.2%
28,611
+1.5%
0.04%
+12.1%
Q3 2019$1,114,000
-79.3%
28,200
-80.4%
0.03%
-93.3%
Q3 2017$5,375,000
+2050.0%
144,017
+1429.0%
0.49%
+1864.0%
Q1 2017$250,0009,4190.02%
Other shareholders
ACCELERON PHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
Novo Holdings A/S 1,103,937$53,563,0005.39%
GREAT POINT PARTNERS LLC 758,000$36,778,0005.10%
Foresite Capital Management II, LLC 244,756$11,876,0004.18%
GREAT POINT PARTNERS LLC 552,300$26,798,0003.71%
Foresite Capital Management III, LLC 278,753$13,525,0002.91%
QVT Financial LP 190,977$9,266,0002.66%
Perceptive Advisors 1,528,205$74,149,0001.94%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,126,800$54,672,0001.92%
SECTORAL ASSET MANAGEMENT INC 306,626$14,877,0001.66%
Parametrica Management Ltd 5,645$274,0001.30%
View complete list of ACCELERON PHARMA INC shareholders